---
figid: PMC9287895__13045_2022_1311_Fig3_HTML
figtitle: Emerging strategies to overcome resistance to third-generation EGFR inhibitors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9287895
filename: 13045_2022_1311_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9287895/figure/Fig3/
number: F3
caption: Molecular mechanisms of acquired resistance. The mechanisms include target
  gene modification, parallel alternative pathway activation, downstream pathway activation,
  and histological/phenotypic transformation. Both amplification and mutation of receptor
  tyrosine kinases (RTKs) can induce downstream survival signaling pathways. Moreover,
  direct overexpression and/or mutation of components of downstream pathways can contribute
  to acquired resistance by promoting cancer cell survival
papertitle: Emerging strategies to overcome resistance to third-generation EGFR inhibitors.
reftext: Kunyu Shi, et al. J Hematol Oncol. 2022;15:94.
year: '2022'
doi: 10.1186/s13045-022-01311-6
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: Epidermal growth factor receptor (EGFR) | Drug resistance | Inhibitors |
  Structureâ€“activity relationship | Tyrosine kinase | Cancer
automl_pathway: 0.9306127
figid_alias: PMC9287895__F3
figtype: Figure
redirect_from: /figures/PMC9287895__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9287895__13045_2022_1311_Fig3_HTML.html
  '@type': Dataset
  description: Molecular mechanisms of acquired resistance. The mechanisms include
    target gene modification, parallel alternative pathway activation, downstream
    pathway activation, and histological/phenotypic transformation. Both amplification
    and mutation of receptor tyrosine kinases (RTKs) can induce downstream survival
    signaling pathways. Moreover, direct overexpression and/or mutation of components
    of downstream pathways can contribute to acquired resistance by promoting cancer
    cell survival
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - btl
  - htl
  - InR
  - ras
  - Ras64B
  - Ras85D
  - Sos
  - drk
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Elk
  - Egfr
  - Shc
  - hop
  - bsk
  - Src42A
  - Csk
  - Src64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Myc
  - Pdk1
  - Akt
  - Pten
  - Mtor
  - Tor
  - Alk
  - Ret
  - reticulated
  - reti
  - rets
  - sl
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - AXL
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - ERBB2
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - ITK
  - SLC22A3
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - EPHB1
  - KCNH8
  - EGFR
  - MTG1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MYC
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - NTRK1
  - PTEN
  - MTOR
  - ALK
  - RET
  - ROS1
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
---
